---
figid: PMC4322985__oncotarget-05-11752-g006
figlink: /pmc/articles/PMC4322985/figure/F6/
number: F6
caption: '[, , ]. (A) Inhibitors of the key downstream effectors of RAS. All downstream
  RAS effectors are cytosolic protein kinases that form a tiered protein kinase cascade
  downstream of RAS. (B) The resistance mechanism against BRAF inhibitor vemurafenib
  (PLX4032).'
pmcid: PMC4322985
papertitle: 'BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential
  signalling and therapeutic implications.'
reftext: Eftychia Oikonomou, et al. Oncotarget. 2014 Dec;5(23):11752-11777.
pmc_ranked_result_index: '68757'
pathway_score: 0.954524
filename: oncotarget-05-11752-g006.jpg
figtitle: 'BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential
  signalling and therapeutic implications'
year: '2014'
organisms:
- Homo sapiens
ndex: bbc46986-de9b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4322985__oncotarget-05-11752-g006.html
  '@type': Dataset
  description: '[, , ]. (A) Inhibitors of the key downstream effectors of RAS. All
    downstream RAS effectors are cytosolic protein kinases that form a tiered protein
    kinase cascade downstream of RAS. (B) The resistance mechanism against BRAF inhibitor
    vemurafenib (PLX4032).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - BRAF
  - PTEN
  - AKT2
  - MAPK1
  - KRAS
  - AKT1
  - RPTOR
  - MAPKAP1
  - MTOR
  - MLST8
  - AKT3
  - ARAF
  - PIK3CG
  - PIK3R3
  - MAPK3
  - PIK3R4
  - PIK3CA
  - MAP2K1
  - MAP2K2
  - PIK3R6
  - RAF1
  - RICTOR
  - PIK3CD
  - NRAS
  - PIK3R5
  - HRAS
  - PIK3CB
  - Temsirolimus
  - PD-0325901
  - Ridaforolimus
  - Selumetinib
  - AZD8055
  - Trametinib
  - GSK2118436
  - Dabrafenib
  - GDC0980
  - AZD2014
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/MTORC1/2Inhibitors
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K/MTORC1/2Inhibitors
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: PD-0325901
  source: MESH
  identifier: C506614
- word: Ridaforolimus
  source: MESH
  identifier: C515074
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: AZD8055
  source: MESH
  identifier: C546624
- word: Trametinib
  source: MESH
  identifier: C560077
- word: GSK2118436
  source: MESH
  identifier: C561627
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: GDC0980
  source: MESH
  identifier: C569670
- word: AZD2014
  source: MESH
  identifier: C585537
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4322985__F6
redirect_from: /figures/PMC4322985__F6
figtype: Figure
---
